Sonic Healthcare (Sonic Healthcare) EBITDA Margin % : 17.40% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Sonic Healthcare EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sonic Healthcare's EBITDA for the six months ended in Dec. 2023 was $501 Mil. Sonic Healthcare's Revenue for the six months ended in Dec. 2023 was $2,882 Mil. Therefore, Sonic Healthcare's EBITDA margin for the quarter that ended in Dec. 2023 was 17.40%.

Sonic Healthcare EBITDA Margin % Historical Data

The historical data trend for Sonic Healthcare's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonic Healthcare EBITDA Margin % Chart

Sonic Healthcare Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBITDA Margin %

Get a 7-Day Free Trial

17.80

20.90

29.28

30.05

21.13

Sonic Healthcare Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial															32.38	27.63	22.65	19.61	17.40

Competitive Comparison of Sonic Healthcare's EBITDA Margin %

For the Diagnostics & Research subindustry, Sonic Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sonic Healthcare's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sonic Healthcare's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sonic Healthcare's EBITDA Margin % falls into.

Sonic Healthcare EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sonic Healthcare's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	1155.128	/	5466.442
	=	21.13 %

Sonic Healthcare's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	501.42	/	2881.959
	=	17.40 %

Sonic Healthcare (OTCPK:SKHHY) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Sonic Healthcare EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Sonic Healthcare's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sonic Healthcare (Sonic Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sonic Healthcare Ltd (OTCPK:SKHHY) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

SKHCF:USA SAB:Germany SHL:Australia

Address

225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000

Website

https://www.sonichealthcare.com

Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S. and 35% in Europe.